| Novo Nordisk Pharma AG - Fiasp ultra-fast-acting Penfill, Injektionslösung | | 66201 | | 01 | | Fiasp ultra-fast-acting Penfill | | Injektionslösung | | A10AB05 | | Insulin aspart | | 07.06.2017 | | |
| | Composition | | insulinum aspartum 600 nmol corresp. insulinum aspartum 100 U., glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. | | Packungsbestandteile | | Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Insuline Aspart | 600 | | Nmol | |
| | BAG: Principe actif | Concentr. |
|---|
| Insuline Aspart | 100 U |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Arginine Hydrochloride | | | | Disodium Phosphate Dihydrate | | | | Glycerol | | | | Metacresol | 1.72 mg/ml | | | Nicotinamide | | | | Phenol | 1.5 mg/ml | conserv. | | Zincum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 5 x 3 ml | 35.48 | 55.00 | B | LS | Oui |
|
|
